Literature DB >> 16965812

Amphiphilic polyanhydrides for protein stabilization and release.

María P Torres1, Amy S Determan, Gretchen L Anderson, Surya K Mallapragada, Balaji Narasimhan.   

Abstract

The overall goal of this research is to design novel amphiphilic biodegradable systems based on polyanhydrides for the stabilization and sustained release of peptides and proteins. Accordingly, copolymers of the anhydrides, 1,6-bis(p-carboxyphenoxy)hexane (CPH) and 1,8-bis(p-carboxyphenoxy)-3,6-dioxaoctane (CPTEG), which are monomer-containing oligomeric ethylene glycol moieties, have been synthesized. Microspheres of different CPTEG:CPH compositions have been fabricated by two non-aqueous methods: solid/oil/oil double emulsion and cryogenic atomization. The ability of this amphiphilic polymeric system to stabilize model proteins (i.e., lysozyme and ovalbumin) was investigated. The structure of both the encapsulated as well as the released protein was monitored using gel electrophoresis, circular dichroism, and fluorescence spectroscopy. It was found that the CPTEG:CPH system preserves the structural hierarchy of the encapsulated proteins. Activity studies of the released protein indicate the CPTEG:CPH system retains the biological activity of the released protein. These results are promising for future in vivo studies, which involve the design of novel biodegradable polyanhydride carriers for the stabilization and sustained release of therapeutic peptides and proteins.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16965812      PMCID: PMC8100984          DOI: 10.1016/j.biomaterials.2006.08.047

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  33 in total

1.  Biodegradation and biocompatibility of PLA and PLGA microspheres.

Authors: 
Journal:  Adv Drug Deliv Rev       Date:  1997-10-13       Impact factor: 15.470

2.  Biopharmaceutical benchmarks--2003.

Authors:  Gary Walsh
Journal:  Nat Biotechnol       Date:  2003-08       Impact factor: 54.908

3.  Sustained release of recombinant human insulin-like growth factor-I for treatment of diabetes.

Authors:  X M Lam; E T Duenas; A L Daugherty; N Levin; J L Cleland
Journal:  J Control Release       Date:  2000-07-03       Impact factor: 9.776

4.  Poly(D,L-lactide-co-glycolide) protein-loaded nanoparticles prepared by the double emulsion method--processing and formulation issues for enhanced entrapment efficiency.

Authors:  U Bilati; E Allémann; E Doelker
Journal:  J Microencapsul       Date:  2005-03       Impact factor: 3.142

5.  Protein stability in the presence of polymer degradation products: consequences for controlled release formulations.

Authors:  Amy S Determan; Jennifer H Wilson; Matt J Kipper; Michael J Wannemuehler; Balaji Narasimhan
Journal:  Biomaterials       Date:  2006-02-28       Impact factor: 12.479

6.  Poly(ethylene glycol) as stabilizer and emulsifying agent: a novel stabilization approach preventing aggregation and inactivation of proteins upon encapsulation in bioerodible polyester microspheres.

Authors:  Ingrid J Castellanos; Rubén Crespo; Kai Griebenow
Journal:  J Control Release       Date:  2003-02-14       Impact factor: 9.776

Review 7.  Biodegradable poly(lactic-co-glycolic acid) microparticles for injectable delivery of vaccine antigens.

Authors:  Wenlei Jiang; Rajesh K Gupta; Mangesh C Deshpande; Steven P Schwendeman
Journal:  Adv Drug Deliv Rev       Date:  2005-01-10       Impact factor: 15.470

8.  Controlled delivery systems for proteins using polyanhydride microspheres.

Authors:  Y Tabata; S Gutta; R Langer
Journal:  Pharm Res       Date:  1993-04       Impact factor: 4.200

9.  Synthesis of novel biodegradable polyanhydrides containing aromatic and glycol functionality for tailoring of hydrophilicity in controlled drug delivery devices.

Authors:  Brandon M Vogel; Surya K Mallapragada
Journal:  Biomaterials       Date:  2005-03       Impact factor: 12.479

10.  The role of microsphere fabrication methods on the stability and release kinetics of ovalbumin encapsulated in polyanhydride microspheres.

Authors:  Amy S Determan; Jennifer R Graham; Katherine A Pfeiffer; Balaji Narasimhan
Journal:  J Microencapsul       Date:  2006-12       Impact factor: 3.142

View more
  40 in total

Review 1.  Nano-enabled delivery of diverse payloads across complex biological barriers.

Authors:  Kathleen A Ross; Timothy M Brenza; Andrea M Binnebose; Yashdeep Phanse; Anumantha G Kanthasamy; Howard E Gendelman; Aliasger K Salem; Lyric C Bartholomay; Bryan H Bellaire; Balaji Narasimhan
Journal:  J Control Release       Date:  2015-08-24       Impact factor: 9.776

2.  Carbohydrate-functionalized nanovaccines preserve HIV-1 antigen stability and activate antigen presenting cells.

Authors:  J E Vela Ramirez; R Roychoudhury; H H Habte; M W Cho; N L B Pohl; B Narasimhan
Journal:  J Biomater Sci Polym Ed       Date:  2014-07-28       Impact factor: 3.517

3.  A single dose polyanhydride-based nanovaccine against paratuberculosis infection.

Authors:  Akanksha Thukral; Kathleen Ross; Chungyi Hansen; Yashdeep Phanse; Balaji Narasimhan; Howard Steinberg; Adel M Talaat
Journal:  NPJ Vaccines       Date:  2020-02-14       Impact factor: 7.344

4.  Neuronal protection against oxidative insult by polyanhydride nanoparticle-based mitochondria-targeted antioxidant therapy.

Authors:  Timothy M Brenza; Shivani Ghaisas; Julia E Vela Ramirez; Dilshan Harischandra; Vellareddy Anantharam; Balaraman Kalyanaraman; Anumantha G Kanthasamy; Balaji Narasimhan
Journal:  Nanomedicine       Date:  2016-10-19       Impact factor: 5.307

5.  Biodegradable polyanhydride-based nanomedicines for blood to brain drug delivery.

Authors:  Timothy M Brenza; Benjamin W Schlichtmann; Biju Bhargavan; Julia E Vela Ramirez; Rainie D Nelson; Matthew G Panthani; JoEllyn M McMillan; Balaraman Kalyanaraman; Howard E Gendelman; Vellareddy Anantharam; Anumantha G Kanthasamy; Surya K Mallapragada; Balaji Narasimhan; Georgette D Kanmogne
Journal:  J Biomed Mater Res A       Date:  2018-10-26       Impact factor: 4.396

6.  High-throughput synthesis of carbohydrates and functionalization of polyanhydride nanoparticles.

Authors:  Brenda R Carrillo-Conde; Rajarshi Roychoudhury; Ana V Chavez-Santoscoy; Balaji Narasimhan; Nicola L B Pohl
Journal:  J Vis Exp       Date:  2012-07-06       Impact factor: 1.355

7.  Amphiphilic polyanhydride nanoparticles stabilize Bacillus anthracis protective antigen.

Authors:  L K Petersen; Y Phanse; A E Ramer-Tait; M J Wannemuehler; B Narasimhan
Journal:  Mol Pharm       Date:  2012-03-20       Impact factor: 4.939

8.  The effect of polyanhydride chemistry in particle-based cancer vaccines on the magnitude of the anti-tumor immune response.

Authors:  Emad I Wafa; Sean M Geary; Jonathan T Goodman; Balaji Narasimhan; Aliasger K Salem
Journal:  Acta Biomater       Date:  2017-01-04       Impact factor: 8.947

9.  Biocompatibility of polysebacic anhydride microparticles with chondrocytes in engineered cartilage.

Authors:  Sathish Ponnurangam; Grace D O'Connell; Clark T Hung; Ponisseril Somasundaran
Journal:  Colloids Surf B Biointerfaces       Date:  2015-08-28       Impact factor: 5.268

10.  Characterizing the antitumor response in mice treated with antigen-loaded polyanhydride microparticles.

Authors:  Vijaya B Joshi; Sean M Geary; Brenda R Carrillo-Conde; Balaji Narasimhan; Aliasger K Salem
Journal:  Acta Biomater       Date:  2012-11-12       Impact factor: 8.947

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.